APA (7th ed.) Citation

D, Y., JW, L., BC, C., EJ, K., JS, K., T, L., . . . YJ, C. (2026). Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypes. Translational lung cancer research, 15(3), 50. https://doi.org/10.21037/tlcr-2025-1-1354

Chicago Style (17th ed.) Citation

D, Yoon, et al. "Molecular and Clinical Disparity of EGFR-mutant Non-small Cell Lung Cancer (NSCLC) Based on Histopathological Stage and EGFR Molecular Subtypes." Translational Lung Cancer Research 15, no. 3 (2026): 50. https://doi.org/10.21037/tlcr-2025-1-1354.

MLA (9th ed.) Citation

D, Yoon, et al. "Molecular and Clinical Disparity of EGFR-mutant Non-small Cell Lung Cancer (NSCLC) Based on Histopathological Stage and EGFR Molecular Subtypes." Translational Lung Cancer Research, vol. 15, no. 3, 2026, p. 50, https://doi.org/10.21037/tlcr-2025-1-1354.